Baron Fund Reports IDEXX Laboratories (IDXX) Holdings and Performance
Published on Β· Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowIn Q2 2026, Baron Focused Growth Fund achieved a 13.26% gain, compared to a 24.02% return for the Russell 2500 Growth Index. IDEXX Laboratories, Inc. (NASDAQ: IDXX), a key holding, closed at $562.20 per share on August 19, 2026, with a market capitalization of $44.29 billion. IDEXX reported a one-month return of 4.23%, but its shares declined by 11.19% over the past 52 weeks. This information highlights the Fund's investment strategy focusing on industry leaders like IDEXX, demonstrating potential market resilience which may interest investors looking for growth in the healthcare sector.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About IDEXX Laboratories Inc. (IDXX)
IDEXX Laboratories provides veterinary diagnostics and software.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier IDXX news
IDXX stock page and all news βGet the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
